MDMA/MDA Reagent Kits
Closed Solicitation Posted
- Solicitation number
- N0018924QZ030
- Agency
- Naval Supply Systems Command Department of the Navy, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Navy Naval Supply Systems Command seeks MDMA/MDA reagent kits for initial immunoassay detection of the designer amphetamines MDMA and MDA in urine samples. The reagent kits must be compatible for use with Beckman Coulter AU5800 Series Clinical Chemistry Analyzers. Bidders must meet the essential criteria in the attached SF 1449. Proposals are due by January 16, 2024.
No set-aside designation applies. The solicitation falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6515 (Drugs and Biologicals). The incumbent or current contractor was not named. The solicitation did not include estimated award values or budget details. Kits will be used to screen an unspecified quantity of urine samples for the presence of MDMA and MDA. Place of performance will be at locations of the Department of the Navy.
Notice text
The materials shall be for the initial (screen) immunoassay for the detection of both of the designer amphetamines, methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA), in urine. The reagent shall be compatible with the Beckman Coulter AU5800 Series Clinical Chemistry Analyzers. Please see attached SF 1449 for essential criteria.
Notice history
| Notice | Type | Posted |
|---|---|---|
| MDMA/MDA Reagent Kits | Solicitation | |
| 6550 - in Vitro Diagnostic Substance Manufacturing | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity